Biogen gets European approval for postpartum depression treatment
Go back to Biogen gets European approval for postpartum depression treatment| BIOGEN IDEC Inc. (NASDAQ: BIIB) | Delayed: 196.58 -2.09 (1.05%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $198.67 | 52 Week High | $333.65 | |||
| Open | $200.22 | 52 Week Low | $223.02 | |||
| Day High | $200.99 | P/E | 25.17 | |||
| Day Low | $193.20 | EPS | $7.81 | |||
| Volume | 1,729,827 | |||||
| SUPERNUS PHARM (NASDAQ: SUPN) | Delayed: 44.38 +0.80 (1.84%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $43.58 | 52 Week High | $26.84 | |||
| Open | $43.67 | 52 Week Low | $9.51 | |||
| Day High | $44.58 | P/E | N/A | |||
| Day Low | $43.54 | EPS | $-2.62 | |||
| Volume | 1,096,030 | |||||
